Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB2 | P05107 | 3/20 | 0.56 |
| ▸ | ICAM1 | P05362 | 3/20 | 0.56 |
| ▸ | ITGAL | P20701 | 3/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.55 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.55 |
| ▸ | CA1 | P00915 | 3/20 | 0.50 |
| ▸ | CA2 | P00918 | 3/20 | 0.50 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.49 |
| ▸ | HRH4 | Q9H3N8 | 3/20 | 0.49 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.49 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | GLA | P06280 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | THPO | P40225 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.48 |
| ▸ | GGT1 | P19440 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5833201 | 0.90 | ITGB2 (0.57) | ITGB2ICAM1ITGALCYP3A4SLC7A5 | |
| SCHEMBL30050868 | 0.88 | ALDH1A1 (0.53) | ITGB2ICAM1ITGALCYP3A4SLC7A5 | |
| SCHEMBL8255250 | 0.86 | ITGB2 (0.54) | ITGB2ICAM1ITGALCYP3A4SLC7A5 | |
| SCHEMBL163397 | 0.83 | ITGB2 (0.60) | ITGB2ICAM1ITGALCYP3A4SLC7A5 | |
| SCHEMBL27043238 | 0.83 | ITGB2 (0.60) | ITGB2ICAM1ITGALCYP3A4SLC7A5 | |
| SCHEMBL151336 | 0.83 | ITGB2 (0.60) | ITGB2ICAM1ITGALCYP3A4SLC7A5 | |
| SCHEMBL12323344 | 0.82 | HRH4 (0.49) | ITGB2ICAM1ITGALCYP3A4SLC7A5 | |
| Hydrochloric Acid SCHEMBL11744091 | 0.82 | ITGB2 (0.59) | ITGB2ICAM1ITGALCYP3A4SLC7A5 | |
| SCHEMBL3378643 | 0.81 | CYP3A4 (0.61) | ITGB2ICAM1ITGALCYP3A4SLC7A5 | |
| SCHEMBL6026427 | 0.81 | ITGB2 (0.64) | ITGB2ICAM1ITGALCYP3A4SLC7A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260139013-A1 | Metal-Binding Bacterial Protein Fibers | VIB VZW (BE) | 2026-05-21 | — | — | US | disclosed |
| US-20260008830-A1 | THERAPEUTIC CYTOKINES AND METHODS | FUND CENTRE DE REGULACIO GENÒMICA (ES) | 2026-01-08 | — | — | US | disclosed |
| EP-4647439-A1 | NON-PATHOGENIC BACTERIA FOR DELIVERY OF PTD-FUSION PROTEINS | Alma Mater Studiorum - Università di Bologna (IT) | 2025-11-12 | — | — | EP | disclosed |
| EP-4602059-A1 | METAL-BINDING BACTERIAL PROTEIN FIBERS | VIB VZW (BE) | 2025-08-20 | — | — | EP | disclosed |
| WO-2025051860-A1 | NOVEL LENTIVIRAL VECTOR PARTICLES | FONDAZIONE TELETHON ETS (IT) | 2025-03-13 | — | — | WO | disclosed |
| EP-4520831-A1 | NOVEL LENTIVIRAL VECTOR PARTICLES | Fondazione Telethon ETS (IT) | 2025-03-12 | — | — | EP | disclosed |
| EP-4469158-A1 | THERAPEUTIC CYTOKINES AND METHODS | Fundació Centre de Regulació Genòmica (ES) | 2024-12-04 | — | — | EP | disclosed |
| CN-118871458-A | Therapeutic cytokines and methods | 基因调控中心基金会 | 2024-10-29 | — | — | CN | disclosed |
| WO-2024079161-A1 | METAL-BINDING BACTERIAL PROTEIN FIBERS | VIB VZW (BE) | 2024-04-18 | — | — | WO | disclosed |
| WO-2023144393-A1 | THERAPEUTIC CYTOKINES AND METHODS | FUNDACIÓ CENTRE DE REGULACIÓ GENÒMICA (ES) | 2023-08-03 | — | — | WO | disclosed |
| CN-114401714-A | Prophylactic or therapeutic agent for renal injury | 特定非盈利活动法人日本生物应力研究振兴联盟 | 2022-04-26 | — | — | CN | disclosed |
| CN-114099623-A | Dehumidifying and itching-relieving ointment and preparation method thereof | 辽宁中医药大学 | 2022-03-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260139013-A1 | Metal-Binding Bacterial Protein Fibers | NAPA, CUTA, EBPL | ITGB2 3344/4885ICAM1 206/4885ITGAL 2824/4885 |
| US-20260008830-A1 | THERAPEUTIC CYTOKINES AND METHODS | IL2, TNF, TNFSF11 | ITGB2 1261/4885ICAM1 862/4885ITGAL 1158/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.